Insider at Esperion (NASDAQ: ESPR) files to sell 1,689 shares

Rhea-AI Filing Summary

Esperion Therapeutics insider plans a small Rule 144 stock sale. A person named Benjamin Looker filed notice to sell 1,689 shares of common stock of Esperion through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $4,867.02 and 239,063,437 common shares outstanding. The shares to be sold were acquired on 01/15/2026 through restricted stock vesting from the issuer as compensation. Over the prior three months, the same seller disposed of 6,517 common shares on 12/17/2025 for gross proceeds of $23,897.19. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about Esperion’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1689	4867.02	239063437	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Restricted Stock Vesting	Issuer			1689	01/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Looker 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	12/17/2025	6517	23897.19

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for ESPR disclose?

The Form 144 discloses that an insider, Benjamin Looker, intends to sell 1,689 shares of Esperion Therapeutics (ESPR) common stock under Rule 144, listing the planned sale details and prior sales.

How many Esperion (ESPR) shares are planned to be sold under this Form 144?

The filing states that 1,689 shares of Esperion common stock are expected to be sold, with an aggregate market value of $4,867.02.

When and how were the ESPR shares being sold acquired?

The 1,689 Esperion shares were acquired on 01/15/2026 through restricted stock vesting from the issuer, described as compensation.

What prior Esperion (ESPR) stock sales by this person are disclosed?

During the past three months, the filing reports that Benjamin Looker sold 6,517 common shares on 12/17/2025 for $23,897.19 in gross proceeds.

On which exchange and through which broker will the ESPR shares be sold?

The planned sale is listed through Fidelity Brokerage Services LLC with the securities to be sold on the NASDAQ exchange.

What representation does the seller make about Esperion in this Form 144?

The seller represents that he does not know any material adverse information regarding Esperion’s current or prospective operations that has not been publicly disclosed.